Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Exp Dermatol ; 43(7): 782-789, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29779219

ABSTRACT

BACKGROUND: Clonal naevi are characterized by a focal proliferation of pigmented melanocytes in an otherwise banal naevus. These subclones are often composed of aggregates of larger, epithelioid melanocytes with nuclear atypia and dusty-grey cytoplasmic pigmentation, which are referred to as 'pulverocytes', and this finding may lead to a misdiagnosis of malignant melanoma (MM). AIM: To characterize the significance of subclones of dusty-grey pigmented epithelioid melanocytes within spitzoid neoplasms. METHODS: We studied the histological and molecular features of a series of 20 spitzoid neoplasms with pulverocyte subclones encountered in our practice, including both atypical Spitz tumours (ASTs) and invasive MMs. RESULTS: Pulverocytes were predominantly dermal, and the percentage of subclones ranged from 2% to 40%, with a median of 10% in ASTs and 25% in lesions we classified as MM. In cases with > 10% subclones, there was an increased odds of fluorescence in situ hybridization positivity (OR = 12; 95% CI 1.2-293.4; P = 0.03) and an increased odds of homozygous 9p21 deletion (OR = 3.6; 95 CI 0.28-89.82; P = 0.33), although the latter did not reach statistical significance. CONCLUSIONS: We consider spitzoid lesions with a small subclone population to be a variant of a clonal naevus with indolent behaviour, whereas lesions with larger pulverocyte populations are more likely to have chromosomal copy number aberrations and in some cases may represent malignant transformation.


Subject(s)
Melanocytes/pathology , Melanoma/pathology , Nevus, Pigmented/pathology , Skin Neoplasms/pathology , Adolescent , Adult , Aged , Child , Child, Preschool , Chromosome Aberrations , Female , Humans , Immunohistochemistry , In Situ Hybridization, Fluorescence , Male , Middle Aged , Nevus, Pigmented/classification , Retrospective Studies
3.
Am J Physiol ; 271(5 Pt 2): R1422-8, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8945982

ABSTRACT

Recombinant human ciliary neurotrophic factor (rh-CNTF) was reported to attenuate skeletal muscle wasting in rats after unilateral transection of the sciatic nerve (M. E. Helgren, S. P. Squinto, H. L. Davis, D. J. Parry, T. G. Bolton, C. S. Heck, Y. Zhu, G. D. Yancopoulos, R. M. Lindsay, and P. S. DiStefano. Cell 76: 493-504, 1994). Under the experimental conditions reported herein, the absolute masses of the denervated gastrocnemius and soleus muscles were not increased in mature or immature rats of either sex by treatment with rhCNTF. At the highest doses of rhCNTF (1 and 0.1 mg/kg), increases in the ratio of the masses of the denervated to the contralateral innervated gastrocnemius and soleus muscles could be attributed entirely to a muscle-wasting effect on the contralateral innervated muscle rather than any muscle-sparing effect on the denervated muscle. The muscle-wasting effects of rhCNTF were associated with reductions in body weight gain and reduced food intake. Pair-fed rats lost less body weight and skeletal muscle mass than rhCNTF-injected freely fed rats but experienced significantly greater loss of visceral mass. Male rats displayed greater loss of body weight and skeletal muscle mass than female rats. Recombinant inhibitors of the cachectic cytokines, tumor necrosis factor and interleukin-1, did not significantly alter the wasting effects of rhCNTF. These findings demonstrate that, in contrast to its well-characterized trophic effects on cells of the nervous system, rhCNTF causes atrophy of skeletal muscle by mechanisms involving both anorexia and cachexia based on the results of pair-feeding experiments.


Subject(s)
Cachexia/physiopathology , Muscle, Skeletal/innervation , Muscle, Skeletal/physiopathology , Nerve Tissue Proteins/pharmacology , Animals , Body Weight/drug effects , Ciliary Neurotrophic Factor , Cytokines/antagonists & inhibitors , Denervation , Female , Humans , Male , Muscular Atrophy/etiology , Muscular Atrophy/prevention & control , Nervous System/physiopathology , Organ Size/drug effects , Rats , Rats, Sprague-Dawley , Recombinant Proteins
4.
Endocrinology ; 135(5): 1913-20, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7525258

ABSTRACT

We have examined the effects of exogenously administered recombinant human insulin-like growth factor-binding protein-1 (rhIGFBP-1) alone and in combination with recombinant human insulin-like growth factor-I (rhIGF-I) or human GH on weight gain and tibial epiphysis enlargement in hypophysectomized rats. rhIGF-I, given twice daily by sc injection, increased both growth parameters in a dose-dependent manner. Coadministration of increasing amounts of rhIGFBP-1 with a constant amount of rhIGF-I (80 micrograms/injection, given twice daily) resulted in a dose-dependent inhibition of the growth-promoting effects of rhIGF-I. A rhIGFBP-1 dose of 9.8 micrograms/injection (an IGFBP-1/IGF-I molar ratio of 0.04:1) caused no significant effect on rhIGF-I-stimulated growth parameters, whereas a rhIGFBP-1 dose of 1200 micrograms/injection (IGFBP-1/IGF-I molar ratio of 5:1) resulted in 78% or greater inhibition of rhIGF-I-stimulated growth (P < 0.05). rhIGFBP-1 doses of 48 and 240 micrograms/injection (IGFBP-1/IGF-I molar ratios of 0.2:1 and 1:1, respectively) had intermediate inhibitory effects. None of the rhIGFBP-1 doses potentiated the growth-promoting effects of rhIGF-I. Rats treated with rhIGFBP-1 alone (twice daily injections of 9.8, 48, 240, or 1200 micrograms) showed no significant differences in growth parameters compared to rats treated with vehicle. Coadministration of rhIGFBP-1 (1200 micrograms/injection, given twice daily) with GH (15 mU/injection, given twice daily) inhibited weight gain and tibial epiphysis enlargement stimulated by GH by at least 50% in each of two experiments (P < 0.05). These studies demonstrate that nonphosphorylated rhIGFBP-1 can inhibit the growth-promoting effects of rhIGF-I and GH in vivo. The results suggest that in addition to its proposed role in glucose homeostasis, IGFBP-1 may play a role in inhibiting somatic growth and other physiological functions stimulated by IGF-I and GH.


Subject(s)
Carrier Proteins/pharmacology , Growth Hormone/pharmacology , Growth/drug effects , Hypophysectomy , Insulin-Like Growth Factor I/pharmacology , Animals , Base Sequence , Dose-Response Relationship, Drug , Drug Interactions , Growth/physiology , Humans , Insulin-Like Growth Factor Binding Protein 1 , Male , Molecular Sequence Data , Rats , Rats, Sprague-Dawley , Recombinant Proteins/pharmacology , Weight Gain/drug effects
5.
Healthc Financ Manage ; 44(3): 66, 1990 Mar.
Article in English | MEDLINE | ID: mdl-10145223
6.
J Chem Ecol ; 11(6): 689-99, 1985 Jun.
Article in English | MEDLINE | ID: mdl-24310215

ABSTRACT

Bioassays were conducted with first-stage larvae and newly emerged females of the southern pine coneworm,Dioryctria amatella (Hulst), to detect feeding and ovipositional preferences for different host-plant materials collected between April and August. Correlations between measures of insect preferences and estimates of wood parameters indicated that larvae preferred to feed on host-plant materials with high moisture contents, low wood densities, and low monoterpene contents. Female moths, however, did not necessarily select those plant materials preferred by larvae for feeding, but tended to oviposit more frequently on materials with high monoterpene contents. A synthetic mixture of monoterpenes similar in composition to those present in fusiform rust galls of slash pine (Pinus elliottii) Englem. var.elliottii) elicited mating and oviposition behavior.

SELECTION OF CITATIONS
SEARCH DETAIL
...